It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
β-Thalassaemia results from defects in β-globin chain production, leading to ineffective erythropoiesis and subsequently to severe anaemia and other complications. Apoptosis and autophagy are the main pathways that regulate the balance between cell survival and cell death in response to diverse cellular stresses. Herein, the death of erythroid lineage cells in the bone marrow from both βIVS2-654-thalassaemic mice and β-thalassaemia/HbE patients was investigated. Phosphatidylserine (PS)-bearing basophilic erythroblasts and polychromatophilic erythroblasts were significantly increased in β-thalassaemia as compared to controls. However, the activation of caspase 8, caspase 9 and caspase 3 was minimal and not different from control in both murine and human thalassaemic erythroblasts. Interestingly, bone marrow erythroblasts from both β-thalassaemic mice and β-thalassaemia/HbE patients had significantly increased autophagy as shown by increased autophagosomes and increased co-localization between LC3 and LAMP-1. Inhibition of autophagy by chloroquine caused significantly increased erythroblast apoptosis. We have demonstrated increased autophagy which led to minimal apoptosis in β-thalassaemic erythroblasts. However, increased PS exposure occurring through other mechanisms in thalassaemic erythroblasts might cause rapid phagocytic removal by macrophages and consequently ineffective erythropoiesis in β-thalassaemia.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Mahidol University, Department of Pathobiology, Faculty of Science, Bangkok, Thailand (GRID:grid.10223.32) (ISNI:0000 0004 1937 0490); Mahidol University, Thalassemia Research Center, Institute of Molecular Biosciences, Nakhon Pathom, Thailand (GRID:grid.10223.32) (ISNI:0000 0004 1937 0490)
2 Mahidol University, Thalassemia Research Center, Institute of Molecular Biosciences, Nakhon Pathom, Thailand (GRID:grid.10223.32) (ISNI:0000 0004 1937 0490)
3 Mahidol University, Thalassemia Research Center, Institute of Molecular Biosciences, Nakhon Pathom, Thailand (GRID:grid.10223.32) (ISNI:0000 0004 1937 0490); Mahidol University, Department of Clinical Microscopy, Faculty of Medical Technology, Bangkok, Thailand (GRID:grid.10223.32) (ISNI:0000 0004 1937 0490)
4 Mahidol University, Thalassemia Research Center, Institute of Molecular Biosciences, Nakhon Pathom, Thailand (GRID:grid.10223.32) (ISNI:0000 0004 1937 0490); Mahidol University, Stem Cell Research Group, Institute of Molecular Biosciences, Nakhon Pathom, Thailand (GRID:grid.10223.32) (ISNI:0000 0004 1937 0490)
5 Mahidol University, Thalassemia Research Center, Institute of Molecular Biosciences, Nakhon Pathom, Thailand (GRID:grid.10223.32) (ISNI:0000 0004 1937 0490); Prince of Songkla University, Faculty of Medical Technology, Songkhla, Thailand (GRID:grid.7130.5) (ISNI:0000 0004 0470 1162)
6 Hudson Institute of Medical Research, Centre for Cancer Research, Melbourne, Australia (GRID:grid.452824.d); Monash University, Department of Molecular and Translational Science, Melbourne, Australia (GRID:grid.1002.3) (ISNI:0000 0004 1936 7857)
7 Mahidol University, Molecular Pathology Laboratory, Institute of Molecular Biosciences, Nakhon Pathom, Thailand (GRID:grid.10223.32) (ISNI:0000 0004 1937 0490)
8 Mahidol University, Thalassemia Research Center, Institute of Molecular Biosciences, Nakhon Pathom, Thailand (GRID:grid.10223.32) (ISNI:0000 0004 1937 0490); Mahidol University, Department of Biochemistry, Faculty of Science, Bangkok, Thailand (GRID:grid.10223.32) (ISNI:0000 0004 1937 0490)




